Northwestern sues Moderna for patent infringement over COVID-19 vaccines

Oct 16 (Reuters) - Moderna (MRNA.O) was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused the company of misusing the school's innovations to develop its blockbuster COVID-19 vaccine Spikevax. The lawsuit said Moderna uses Northwestern-developed lipid nanoparticle (LNP) technology without a license in Spikevax shots to transport fragile messenger RNA into the human body. A Moderna spokesperson said the company was aware of the lawsuit and will defend itself against the claims. Attorneys and spokespeople for Northwestern did not immediately respond...